Portales de hepatología

CDC: Viral Hepatitis Clinical Care Options: Hepatitis Grupo Español para el Estudio de las Hepatopatías Asociadas a Medicamentos Hepatitis Drug Interactions Hepatic Pathology Index HepatitisBforum Hepatoevaluación Hepatoinfo Hepatonews HepChange HIVandHepatitis.com National AIDS Treatment Advocacy Project (NATAP) Registro Español de Trasplante Hepático Review of Pathology of the Liver Sociedad Española de Trasplante Hepático Viral Hepatitis Prevention Board

Resúmenes de Congresos

62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco, 4-8 noviembre 2011 HIVandHepatitis.com NATAP 46th Annual Meeting of the European Association for the Study of the Liver Berlin, 30 marzo-3 abril 2011 Journal of Hepatology 2011;54 (Supl. 1) HIVandHepatitis.com Clinical Care Options - Hepatitis NATAP XXXVI Congreso Anual de la Fundación/Asociación Española para el Estudio del Hígado Madrid, 23-25 febrero 2011 Gastroenterología y Hepatología 2011;34 (Especial Congreso 1) Poster Gallery

Guías de práctica clínica

The Management of Acute Liver Failure: Update 2011 (AASLD Position Paper).  Hepatology (en prensa) An update on treatment of genotype 1 chronic hepatitis C virus infection. Hepatology 2011;54:1433-1444 Diagnosis and management of hemochromatosis. Hepatology 2011;54:328-343 Management of hepatocellular carcinoma: An update. Hepatology 2011;53:1020-1022 Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193-2213 Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660-678 Alcoholic liver disease. Hepatology 2010;51:307-328 The role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the management of portal hypertension: Update 2009. Hepatology 2010;51:306 Chronic hepatitis B: Update 2009. Hepatology 2009;50:661-662 Primary Biliary Cirrhosis. Hepatology 2009;450:291-308 Management of adult patients with ascites due to cirrhosis: An update. Hepatology 2009;49:2087-2107 Vascular disorders of the liver. Hepatology 2009;49:1729-1764 Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 2009;49:1335-1374 Liver biopsy (AASLD Position Paper). Hepatology 2009;49:1017-1044 Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089-2111 Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922-938 Chronic hepatitis B. Hepatology 2007;45:507-539 Evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-1432 The management of acute liver failure. Hepatology 2005;41:1179-1197 Laboratory guidelines for screening, diagnosis and monitoring of hepatic injury. Clinical Chemistry 2000;46:2027-2049 y Clinical Chemistry 2000;46:2050-2068		Management of hepatitis C virus infection. Journal of Hepatology 2011;55:245-264 Management of ascitis, spontaneous bacterial peritonitis and hepatorrenal syndrome in cirrhosis. Journal of Hepatology 2010;53:397-417 HFE hemochromatosis. Journal of Hepatology 2010;53:3-22 Management of cholestatic liver diseases. Journal of Hepatology 2009;51:237-267 Management of chronic hepatitis B. Journal of Hepatology 2009;50:227-242 AGA Medical Position Statement - Management of hepatitis C. Gastroenterology 2006;130:225-230 AGA Technical Review - Management of hepatitis C. Gastroenterology 2006;130:231-264 AGA Medical Position Statement - Osteoporosis in hepatic disorders. Gastroenterology 2003;125:937-940 AGA Technical Review - Osteoporosis in hepatic disorders. Gastroenterology 2003;125:941-966 AGA Medical Position Statement - Nonalcoholic fatty liver disease. Gastroenterology 2002;123:1702-1704 AGA Technical Review - Nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705-1725 AGA Medical Position Statement - Evaluation of liver chemistry tests. Gastroenterology 2002;123:1364-1366 AGA Technical ReviewEvaluation of liver chemistry tests. Gastroenterology 2002;123:1367-1384

Calculadoras

Pronóstico de la cirrosis hepática Child-Pugh, MELD y MELD-Na TTMed Hepatología (*) Child-Pugh Hepatoinfo MELD Hepatoinfo MELD original Mayo Clinic MELD modificado por la UNOS Mayo Clinic MELD modificado por la UNOS United Network for Organ Sharing MELD-Na Mayo Clinic Miscelánea Estadificación del hepatocarcinoma (BCLC y otros criterios) J. Primo Diagnóstico de la hepatitis autoinmune TTMed Hepatología (*) Toxicidad hepática causada por fármacos J. Primo Predicción de fibrosis hepática en hepatitis C recurrente tras trasplante hepático Benlloch S et al. Liver Transpl 2005;11:456-462. Riesgo de mortalidad postoperatoria en la cirrosis hepática Mayo Clinic Índices de fibrosis hepática TTMed Hepatología (*) Criterios para la indicación de trasplante hepático en la insuficiencia hepática aguda grave TTMed Hepatología (*) Predicción de la respuesta al tratamiento en la hepatitis C crónica genotipo 1 con los modelos PreT-SM y 4w-SM TTMed Hepatología (*) Índices para la valoración de la encefalopatía hepática TTMed Hepatología (*)		Enfermedades colestásicas crónicas Índices pronósticos en la cirrosis biliar primaria y en la colangitis esclerosante primaria TTMed Hepatología (*) Pronóstico de la cirrosis biliar primaria a largo plazo sin tratamiento Mayo Clinic Pronóstico de la cirrosis biliar primaria a largo plazo sin tratamiento Hepatoinfo Pronóstico de la cirrosis biliar primaria a corto plazo y con tratamiento Mayo Clinic Pronóstico de la colangitis esclerosante primaria (modelo revisado) Mayo Clinic Riesgo de complicaciones tras trasplante hepático en la cirrosis biliar primaria y en la colangitis esclerosante primaria Mayo Clinic Hepatopatía alcohólica Pronóstico de la hepatitis alcohólica TTMed Hepatología (*) Pronóstico de la hepatitis alcohólica aguda (modelo de Lille) Centre Hospitalier Régional Universitarie de Lille Pronóstico de la hepatitis alcohólica aguda (coeficiente de Maddrey) Centre Hospitalier Régional Universitarie de Lille Predicción de mortalidad a los 3 meses de la hepatitis alcohólica aguda con el MELD Mayo Clinic Distinción entre hepatopatía alcohólica y enfermedad hepática grasa no alcohólica (ANI score) Mayo Clinic Función renal Aclaramiento de creatinina (Cockcroft-Gault) y filtrado glomerular (MDRD) Sociedad Española de Nefrología
(*) Alojadas originalmente en Timely Topics in Medicine - Hepatología

Conferencias de consenso

Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. Journal of Hepatology 2011;54:374-385 Revising Consensus in Portal Hypertension: Report of the Baveno V Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology 2010;53:762-768 Diagnóstico y tratamiento del carcinoma hepatocelular. Med Clin (Barc) 2009;132:272-287 NIH Consensus Development Conference: Management of Hepatitis B. Hepatology 2009;49 (Supl. 5):S1-S199 Documento de consenso de la SETH sobre lista de espera, trasplante pediátrico e indicadores de calidad. Gastroenterol Hepatol 2009;32:702-716 International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-176 Documento de consenso de la SETH sobre acceso al trasplante hepático, indicaciones controvertidas, priorización de la lista de espera e indicadores de calidad. Gastroenterol Hepatol 2008;31:82-91 Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis. Journal of Hepatology 2006:45:127-143 Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. Journal of Hepatology 2004;41:677-683 Screening in liver disease: Report of an AASLD clinical workshop. Hepatology 2004;39:1204-1212 Documento de consenso de la AEEH sobre indicaciones de trasplante hepático. Gastroenterol Hepatol 2003;26:355-375 Hepatic encephalopathy - Definition, nomenclature, diagnosis and quantification: Final Report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-721 Trasplante de progenitores hematopoyéticos en pacientes y/o de donantes con infección por los virus de la hepatitis B o C: revisión y recomendaciones. Med Clin (Barc) 2002;118:268-277 International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938

Otros enlaces

Management of Liver Diseases 2012 - J Hepatol 2012;56(Supl.1)  The 2011 Short Guide to Hepatitis C Hepatology 2010 - A clinical textbook Management of Liver Diseases 2008 - J Hepatol 2008;48(Supl.1) Management of Liver Diseases 2005 - J Hepatol 2005;42(Supl.1) Therapy in Liver Diseases 2003 - J Hepatol 2003;38(Supl.1)

EASL Meeting Reports

Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology 2008;49:652-657 Immunological techniques in viral hepatitis. Journal of Hepatology 2007;46:1143-1148 Genetics in liver diseases. Journal of Hepatology 2007;46:508-520

AASLD Single Topic Conferences

Hepatocellular carcinoma. Hepatology 2004;40:1465-1473 Nonalcoholic steatohepatitis. Hepatology 2003;37:1202-1219

Recomendaciones de profilaxis

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR 2008;57(RR08):1-20 A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR 2006;55(RR-16) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part I: immunization of infants, children, and adolescents. MMWR 2005;54(RR-16) Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2004;140:465-479 Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR 2003;52(RR-3):1-13 Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR 2001;50(RR-11) Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(RR-12) Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(RR-19)